TABLE OF CONTENTS
Volume 68, Issue 4 (October 2005)
Cardiovascular and Renal Progression Factors in Chronic Kidney Disease |
Perspectives in Renal Medicine |
Perspectives in Basic Science |
Genetic Disorders – Development |
Hormones – Cytokines – Signaling |
Cell Biology – Immunology – Pathology |
Ion Channels – Membrane Transport – Integrative Physiology |
Vascular Biology – Hemodynamics – Hypertension |
Clinical Nephrology – Epidemiology – Clinical Trials |
Dialysis – Transplantation |
Technical Notes |
Editorials |
Letters to the Editor |
Nephrology Forum |
International Society of Nephrology
A Tribute to Comgan
The global perspective of the International Society of Nephrology: A decade of experience with COMGAN
JOHN H DIRKS and SHEILA W ROBINSON
Kidney Int 68: 1395-1410; doi:10.1111/j.1523-1755.2005.00549.x
Cardiovascular and Renal Progression Factors in Chronic Kidney Disease
Cardiovascular and Renal Progression Factors in Chronic Kidney Disease: A Colloquium in Honor of John H. Dirks ISN World Congress of Nephrology Singapore, June 26, 2005
BARRY M BRENNER
Kidney Int 68: 1411-1412; doi:10.1111/j.1523-1755.2005.00550.x
Cardiovascular risk factors in chronic kidney disease
VANDANA MENON, AMBREEN GUL and MARK J SARNAK
Kidney Int 68: 1413-1418; doi:10.1111/j.1523-1755.2005.00551.x
Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment
JOHN J V MCMURRAY
Kidney Int 68: 1419-1426; doi:10.1111/j.1523-1755.2005.00552.x
Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: Baseline results
DAVID G WARNOCK, WILLIAM MCCLELLAN, LESLIE A MCCLURE, BRITT NEWSOME, RUTH C CAMPBELL, PAUL AUDHYA, MARY CUSHMAN, VIRGINIA J HOWARD and GEORGE HOWARD
Kidney Int 68: 1427-1431; doi:10.1111/j.1523-1755.2005.00553.x
Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease
MADHUMATHI RAO and BRIAN J G PEREIRA
Kidney Int 68: 1432-1438; doi:10.1111/j.1523-1755.2005.00554.x
Targets to retard the progression of diabetic nephropathy
MARK E COOPER, KARIN JANDELEIT-DAHM and MERLIN C THOMAS
Kidney Int 68: 1439-1445; doi:10.1111/j.1523-1755.2005.00555.x
Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study
PETER ROSSING, PHILIP HOUGAARD and HANS-HENRIK PARVING
Kidney Int 68: 1446-1450; doi:10.1111/j.1523-1755.2005.00556.x
Closing remarks
JOHN H DIRKS
Kidney Int 68: 1451-1452; doi:10.1111/j.1523-1755.2005.00557.x
Perspectives in Renal Medicine
Posttransplantation chronic renal damage in nonrenal transplant recipients
PIERO STRATTA, CATERINA CANAVESE, MARCO QUAGLIA, FEDERICO BALZOLA, MARCO BOBBIO, ALESSANDRO BUSCA, ALESSANDRO FRANCHELLO, DANIELA LIBERTUCCI and GIANNA MAZZUCCO
Kidney Int 68: 1453-1463; doi:10.1111/j.1523-1755.2005.00558.x
Perspectives in Basic Science
Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement
MORIE A GERTZ, NELSON LEUNG, MARTHA Q LACY and ANGELA DISPENZIERI
Kidney Int 68: 1464-1471; doi:10.1111/j.1523-1755.2005.00559.x
Genetic Disorders – Development
Mapping of a new candidate locus for uromodulin-associated kidney disease (UAKD) to chromosome 1q41
KATE
INA HODA
OVÁ, JACEK MAJEWSKI, MARTINA KUBLOVÁ, PETR VYLEŤAL, MARIE KALBÁ
OVÁ, BLANKA STIB
RKOVÁ, HELENA H
LKOVÁ, YVON C CHAGNON, CHRISTIAN-MARC LANOUETTE, ANTHONY MARINAKI, JEAN-PIERRE FRYNS, GOPALAKRISHNAN VENKAT-RAMAN and STANISLAV KMOCH
Kidney Int 68: 1472-1482; doi:10.1111/j.1523-1755.2005.00560.x
Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy
SYLVIA SCHÖN, CHRISTIAN PRANTE, SANDRA MÜLLER, MANUELA SCHÖTTLER, LISE TARNOW, JOACHIM KUHN, KNUT KLEESIEK and CHRISTIAN GÖTTING
Kidney Int 68: 1483-1490; doi:10.1111/j.1523-1755.2005.00561.x
Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]Rapid Communication
GANG XU, VIBHA BHATNAGAR, GEN WEN, BRUCE A HAMILTON, SATISH A ERALY and SANJAY K NIGAM
Kidney Int 68: 1491-1499; doi:10.1111/j.1523-1755.2005.00612.x
Hormones – Cytokines – Signaling
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression
YINGJIAN LI, BRADLEY C SPATARO, JUNWEI YANG, CHUNSUN DAI and YOUHUA LIU
Kidney Int 68: 1500-1510; doi:10.1111/j.1523-1755.2005.00562.x
Induction of Zf9 in the kidney following early ischemia/reperfusion
RIDWAN TARABISHI, KAMYAR ZAHEDI, JAYA MISHRA, QING MA, CAITLIN KELLY, KATHY TEHRANI and PRASAD DEVARAJAN
Kidney Int 68: 1511-1519; doi:10.1111/j.1523-1755.2005.00563.x
Cell Biology – Immunology – Pathology
Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells
UTA KUNTER, SOIZIC DANIEL, MARIA B ARVELO, JEAN CHOI, TALA SHUKRI, VIRENDRA I PATEL, CHRISTOPHER R LONGO, SALVATORE T SCALI, GAUTAM SHRIKHANDE, EDUARDO ROCHA, EVA CZISMADIA, CHRISTINA MOTTLEY, SHANE T GREY, JÜRGEN FLOEGE and CHRISTIANE FERRAN
Kidney Int 68: 1520-1532; doi:10.1111/j.1523-1755.2005.00564.x
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy
RICHARD A ZAGER
Kidney Int 68: 1533-1542; doi:10.1111/j.1523-1755.2005.00565.x
Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells
MARIEKE S J SCHEPERS, EDDY S VAN BALLEGOOIJEN, CHRIS H BANGMA and CARL F VERKOELEN
Kidney Int 68: 1543-1553; doi:10.1111/j.1523-1755.2005.00566.x
Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy
MARGO P COHEN, SHELDON CHEN, FUAD N ZIYADEH, ELIZABETH SHEA, ELIZABETH A HUD, GREGORY T LAUTENSLAGER and CLYDE W SHEARMAN
Kidney Int 68: 1554-1561; doi:10.1111/j.1523-1755.2005.00567.x
The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis
HENRY DIJKMAN, BART SMEETS, JEROEN VAN DER LAAK, ERIC STEENBERGEN and JACK WETZELS
Kidney Int 68: 1562-1572; doi:10.1111/j.1523-1755.2005.00568.x
See also: Editorial by SCHWARTZCREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress
ISTVAN ARANY, JUDIT K MEGYESI, JANE E B REUSCH and ROBERT L SAFIRSTEIN
Kidney Int 68: 1573-1582; doi:10.1111/j.1523-1755.2005.00569.x
p27Kip1 knockout mice are protected from diabetic nephropathy: Evidence for p27Kip1 haplotype insufficiency
GUNTER WOLF, ANJA SCHANZE, ROLF A K STAHL, STUART J SHANKLAND and KERSTIN AMANN
Kidney Int 68: 1583-1589; doi:10.1111/j.1523-1755.2005.00570.x
See also: Editorial by QI & BREYERMatrix metalloproteinases and mesangial remodeling in light chain–related glomerular damage
JOHN KEELING and GUILLERMO A HERRERA
Kidney Int 68: 1590-1603; doi:10.1111/j.1523-1755.2005.00571.x
Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naïve B cells
JAN-WILLEM EIJGENRAAM, ANDREA M WOLTMAN, SYLVIA W A KAMERLING, FRANCINE BRIERE, JOHAN W DE FIJTER, MOHAMED R DAHA and CEES VAN KOOTEN
Kidney Int 68: 1604-1612; doi:10.1111/j.1523-1755.2005.00572.x
Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion–induced acute renal failure in rats
CLAUDIA LANGE, FLORIAN TÖGEL, HARALD ITTRICH, FREDERIC CLAYTON, CLAUS NOLTE-ERNSTING, AXEL R ZANDER and CHRISTOF WESTENFELDER
Kidney Int 68: 1613-1617; doi:10.1111/j.1523-1755.2005.00573.x
The cyclin-dependent kinase inhibitor p21 is required for TGF-
1–induced podocyte apoptosis
TAKEHIKO WADA, JEFFREY W PIPPIN, YOSHIO TERADA and STUART J SHANKLAND
Kidney Int 68: 1618-1629; doi:10.1111/j.1523-1755.2005.00574.x
Characterization of glycosaminoglycans in tubular epithelial cells: Calcium oxalate and oxalate ions effects
FERNANDA T BORGES, YARA M MICHELACCI, JAIR A K AGUIAR, MARIA A DALBONI, ANDREZZA S GARÓFALO and NESTOR SCHOR
Kidney Int 68: 1630-1642; doi:10.1111/j.1523-1755.2005.00577.x
Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis
ANJA VERHULST, MARINO ASSELMAN, STEPHANIE DE NAEYER, BENJAMIN A VERVAET, MICHAEL MENGEL, WILFRIED GWINNER, PATRICK C D'HAESE, CARL F VERKOELEN and MARC E DE BROE
Kidney Int 68: 1643-1647; doi:10.1111/j.1523-1755.2005.00584.x
VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells
DENIS FELIERS, XIAOYAN CHEN, NESE AKIS, GOUTAM GHOSH CHOUDHURY, MICHAEL MADAIO and BALAKUNTALAM S KASINATH
Kidney Int 68: 1648-1659; doi:10.1111/j.1523-1755.2005.00575.x
Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations
MARIEKE S J SCHEPERS, EDDY S VAN BALLEGOOIJEN, CHRIS H BANGMA and CARL F VERKOELEN
Kidney Int 68: 1660-1669; doi:10.1111/j.1523-1755.2005.00576.x
Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development
YASHPAL S KANWAR, SHIGERU AKAGI, BAIBASWATA NAYAK, LIN SUN, JUN WADA, PING XIE, ARUN THAKUR, SUMANT S CHUGH and FARHAD R DANESH
Kidney Int 68: 1670-1683; doi:10.1111/j.1523-1755.2005.00611.x
Ion Channels – Membrane Transport – Integrative Physiology
Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1
RUDOLFS K ZALUPS and SARFARAZ AHMAD
Kidney Int 68: 1684-1699; doi:10.1111/j.1523-1755.2005.00585.x
Prolactin, a natriuretic hormone, interacting with the renal dopamine system
FERNANDO IBARRA, SUSANNE CRAMBERT, ANN-CHRISTINE EKLÖF, ANNIKA LUNDQUIST, PETER HANSELL and ULLA HOLTBÄCK
Kidney Int 68: 1700-1707; doi:10.1111/j.1523-1755.2005.00586.x
Coordinated control of renal Ca2+ transport proteins by parathyroid hormone
MONIQUE VAN ABEL, JOOST G J HOENDEROP, ANNEMIETE W C M VAN DER KEMP, MICHAEL M FRIEDLAENDER, JOHANNES P T M VAN LEEUWEN and RENÉ J M BINDELS
Kidney Int 68: 1708-1721; doi:10.1111/j.1523-1755.2005.00587.x
Vascular Biology – Hemodynamics – Hypertension
Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes
DAVID Z I CHERNEY, ETIENNE B SOCHETT and JUDITH A MILLER
Kidney Int 68: 1722-1728; doi:10.1111/j.1523-1755.2005.00588.x
Gender hormones and the progression of experimental polycystic kidney disease
KENNETH D STRINGER, RADKO KOMERS, SHUKRI A OSMAN, TERRY T OYAMA, JESSIE N LINDSLEY and SHARON ANDERSON
Kidney Int 68: 1729-1739; doi:10.1111/j.1523-1755.2005.00589.x
Clinical Nephrology – Epidemiology – Clinical Trials
The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study
RAKESH AMIN, CHARLES TURNER, SARA VAN AKEN, TERESA KONOPELSKA BAHU, ANGELA WATTS, DAVID R M LINDSELL, R NEIL DALTON and DAVID B DUNGER
Kidney Int 68: 1740-1749; doi:10.1111/j.1523-1755.2005.00590.x
Lamivudine in hepatitis B–associated membranous nephropathy
SYDNEY TANG, FERNAND MAC-MOUNE LAI, YUN HOI LUI, COLIN S O TANG, NELSON N S KUNG, YIU WING HO, KWOK WAH CHAN, JOSEPH C K LEUNG and KAR NENG LAI
Kidney Int 68: 1750-1758; doi:10.1111/j.1523-1755.2005.00591.x
Darbepoetin alfa (AranespTM) in children with chronic renal failure
DENIS F GEARY, LAURA E KEATING, ANNETTE VIGNEUX, DEREK STEPHENS, DIANE HÉBERT and ELIZABETH A HARVEY
Kidney Int 68: 1759-1765; doi:10.1111/j.1523-1755.2005.00592.x
Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?
JOHANNA T DWYER, BRETT LARIVE, JUNE LEUNG, MICHAEL V ROCCO, TOM GREENE, JERRILYNN BURROWES, GLENN M CHERTOW, DAVID B COCKRAM, W CAMERON CHUMLEA, JOHN DAUGIRDAS, ANNE FRYDRYCH and JOHN W KUSEK FORTHE HEMO STUDY GROUP
Kidney Int 68: 1766-1776; doi:10.1111/j.1523-1755.2005.00593.x
The impact of education on chronic kidney disease patients' plans to initiate dialysis with self-care dialysis: A randomized trial
BRADEN J MANNS, KEN TAUB, CARMEN VANDERSTRAETEN, HEATHER JONES, CYNTHIA MILLS, MARILYN VISSER and KEVIN MCLAUGHLIN
Kidney Int 68: 1777-1783; doi:10.1111/j.1523-1755.2005.00594.x
Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers
VIVEK KUMAR, LOURDES PEÑA DE LA VEGA, GERARD FARELL and JOHN C LIESKE
Kidney Int 68: 1784-1792; doi:10.1111/j.1523-1755.2005.00595.x
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
JOHN CUNNINGHAM, MARK DANESE, KURT OLSON, PRESTON KLASSEN and GLENN M CHERTOW
Kidney Int 68: 1793-1800; doi:10.1111/j.1523-1755.2005.00596.x
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients
BRUCE S SPINOWITZ, MICHAEL H SCHWENK, PAULA M JACOBS, W KLINE BOLTON, MARK R KAPLAN, CHAIM CHARYTAN and MARILYN GALLER
Kidney Int 68: 1801-1807; doi:10.1111/j.1523-1755.2005.00598.x
Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management?
CHRISTOPHER S SAIGAL, GEOFFREY JOYCE, ANGA R TIMILSINA and THE UROLOGIC DISEASES IN AMERICA PROJECT
Kidney Int 68: 1808-1814; doi:10.1111/j.1523-1755.2005.00599.x
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GEOFFREY A BLOCK, DAVID M SPIEGEL, JAMES EHRLICH, RAVINDRA MEHTA, JILL LINDBERGH, ALBERT DREISBACH and PAOLO RAGGI
Kidney Int 68: 1815-1824; doi:10.1111/j.1523-1755.2005.00600.x
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus
BRAD H ROVIN, HUIJUAN SONG, LEE A HEBERT, TIBOR NADASDY, GYONGYI NADASDY, DANIEL J BIRMINGHAM, CHACK YUNG YU and HAIKADY N NAGARAJA
Kidney Int 68: 1825-1833; doi:10.1111/j.1523-1755.2005.00601.x
Dialysis – Transplantation
BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients
BRAHM VASUDEV, SUNDARAM HARIHARAN, SYED A HUSSAIN, YONG-RAN ZHU, BARBARA A BRESNAHAN and ERIC P COHEN
Kidney Int 68: 1834-1839; doi:10.1111/j.1523-1755.2005.00602.x
25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy
GIORGIO COEN, DANIELA MANTELLA, MICAELA MANNI, ALESSANDRO BALDUCCI, ITALO NOFRONI, DANIELA SARDELLA, PAOLA BALLANTI and ERMANNO BONUCCI
Kidney Int 68: 1840-1848; doi:10.1111/j.1523-1755.2005.00603.x
The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis
ALENA PARIKOVA, WATSKE SMIT, DIRK G STRUIJK, MACHTELD M ZWEERS and RAYMOND T KREDIET
Kidney Int 68: 1849-1856; doi:10.1111/j.1523-1755.2005.00604.x
Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus
LARA B PUPIM, PAUL J FLAKOLL, KAREN M MAJCHRZAK, DEANNA L AFTAB GUY, PETER STENVINKEL and T ALP IKIZLER
Kidney Int 68: 1857-1865; doi:10.1111/j.1523-1755.2005.00605.x
Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status
KATHRYN J TINCKAM, OGNJENKA DJURDJEV and ALEX B MAGIL
Kidney Int 68: 1866-1874; doi:10.1111/j.1523-1755.2005.00606.x
Technical Notes
A novel biological assay to detect the active form of TGF-
in urine to monitor renal allograft rejection
EDITH ROGIER, ANTOINE DURRBACH, LUCILE ABECASSIS, SOPHIE FERLICOT, RENAUD SNANOUDJ, SEVERINE BAUDREUIL, NADIA ARZOUK, AIME VAZQUEZ, BERNARD CHARPENTIER and MARIE-FRANÇOISE BOURGEADE
Kidney Int 68: 1875-1883; doi:10.1111/j.1523-1755.2005.00607.x
Variation in the serum creatinine assay calibration: A practical application to glomerular filtration rate estimation
KALYANI MURTHY, LESLEY A STEVENS, PAUL C STARK and ANDREW S LEVEY
Kidney Int 68: 1884-1887; doi:10.1111/j.1523-1755.2005.00608.x
Low calorie commercial sugar is a sensitive marker of glomerular filtration rate
JAZMIN M PÉREZ-ROJAS, JORGE A BLANCO, GERARDO GAMBA and NORMA A BOBADILLA
Kidney Int 68: 1888-1893; doi:10.1111/j.1523-1755.2005.00609.x
Editorials
The blind men and the elephant
MELVIN M SCHWARTZ
Kidney Int 68: 1894-1895; doi:10.1111/j.1523-1755.2005.00613.x
See also: Cell Biology – Immunology – Pathology by DIJKMAN et al.Diabetic nephropathy: Big and bad
ZHONGHUA QI and MATTHEW D BREYER
Kidney Int 68: 1896-1897; doi:10.1111/j.1523-1755.2005.00614.x
See also: Cell Biology – Immunology – Pathology by WOLF et al.Letters to the Editor
Combination renin-angiotensin system blackade in hypertension
TIMOTHY W R DOULTON and GRAHAM A MACGREGOR
Kidney Int 68: 1898; doi:10.1111/j.1523-1755.2005.00578.x
CD4+CD25+ regulatory T cells: A new treatment option in glomerulonephritis
KATHRIN HOCHEGGER, DOMINIK WOLF and ALEXANDER R ROSENKRANZ
Kidney Int 68: 1898-1899; doi:10.1111/j.1523-1755.2005.00578.x
Aldosterone-mediated endothelial remodeling and oxidative stress
LORENZO A CALÒ and DECIO ARMANINI
Kidney Int 68: 1899; doi:10.1111/j.1523-1755.2005.00578.x
Screening for microalbuminuria
LUUK B HILBRANDS, FRANS T HUYSMANS and JACK F WETZELS
Kidney Int 68: 1899-1900; doi:10.1111/j.1523-1755.2005.00578.x
See also: Letter to the Editor by DE JONG et al.Reply from the Authors
PAUL E DE JONG, BARRY M BRENNER and DICK DE ZEEUW
Kidney Int 68: 1901-1902; doi:10.1111/j.1523-1755.2005.00578.x
See also: Letter to the Editor by HILBRANDS et al.Diaphragmed fenestrae in the glomerular endothelium versus nondiaphragmed fenestrae in the hepatic endothelium
FILIP BRAET and LILIAN L SOON
Kidney Int 68: 1902; doi:10.1111/j.1523-1755.2005.00578.x
See also: Letter to the Editor by BALLERMANNReply from the Authors
BARBARA J BALLERMANN
Kidney Int 68: 1902-1903; doi:10.1111/j.1523-1755.2005.00578.x
See also: Letter to the Editor by BRAET & SOONImmunosuppressive and calcimimetic drug-drug interactions
HASSANE IZZEDINE, VINCENT LAUNAY-VACHER, SVETLANA KARIE and GILBERT DERAY
Kidney Int 68: 1903-1904; doi:10.1111/j.1523-1755.2005.00578.x
Nephrology Forum
Filtration function in glomerulonephritis
KAMAL F BADR Principal discussant:
Kidney Int 68: 1905-1919; doi:10.1111/j.1523-1755.2005.00610.x
International Society of Nephrology
MEETING ANNOUNCEMENTS
Kidney Int 68: 1921; doi:10.1111/j.1523-1755.2005.90684.x


